Santen Pharmaceutical competitive analysis

Latest publications and patents of Santen Pharmaceutical New

Explore the latest publications and patents granted to Santen Pharmaceutical, showcasing their recent innovations and technological advancements.

Last updated on: Sep 29, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Santen Pharmaceutical

Aug 31, 2022Atropine-Containing Aqueous CompositionGranted And Under Opposition
Jan 26, 2022Method And Composition For Treating Ocular Hypertension And GlaucomaGranted And Under Opposition
Apr 29, 2020Method And Composition For Treating Ocular Hypertension And GlaucomaGranted And Under Opposition
May 3, 2017Method And Composition For Treating Ocular Hypertension And GlaucomaRevoked

Explore Santen Pharmaceutical's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 2, 2025
Patent NumberGrant DateTitleTotal Oppositions
Aug 31, 2022Atropine-Containing Aqueous Composition2
Jan 26, 2022Method And Composition For Treating Ocular Hypertension And Glaucoma3
Apr 29, 2020Method And Composition For Treating Ocular Hypertension And Glaucoma1
May 3, 2017Method And Composition For Treating Ocular Hypertension And Glaucoma1

Latest PTAB cases involving Santen Pharmaceutical

Discover the latest PTAB cases involving Santen Pharmaceutical, highlighting their recent legal challenges and patent disputes.

Last updated on: Oct 5, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Santen Pharmaceutical

IPR2017-01434May 12, 2017MICRO LABSSANTEN PHARMACEUTICALFinal Written Decision

Peer Comparison New

IP litigation analysis comparing Santen Pharmaceutical with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
SANTEN PHARMACEUTICAL - 7 - 1Non-Active
BECKER61 - - Highly Aggressive
COOKE27 - - - Highly Aggressive
DE GREGORI1 - - - Highly Aggressive